ABBV-319
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ABBV-319, covering 2026-01-16 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE) and Sjogren's Disease (SjD) [Phase 1]